A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

被引：0

作者：

Chukwueke, Ugonma ^{[1
]}

Wright, Isobel ^{[1
]}

Muzikansky, Alona ^{[2
]}

Russ, Alyssa ^{[1
]}

Fontana, Brittney ^{[1
]}

Kats, Vanessa ^{[1
]}

O'Donnell, Colin ^{[3
]}

Scalfani, Renee ^{[1
]}

Acevedo-Naranjo, Brenda ^{[1
]}

Lee, Eudocia ^{[1
]}

Castro, Luis Nicolas Gonzalez ^{[4
]}

McFaline-Figueroa, Jose Ricardo ^{[4
]}

Aquilanti, Elisa ^{[1
]}

Youssef, Gilbert ^{[4
]}

Beroukhim, Rameen ^{[4
]}

Forst, Deborah ^{[5
]}

Reardon, David

Wen, Patrick ^{[6
]}

Batchelor, Tracy ^{[1
]}

Torres, Alexandra ^{[1
]}

Stefanik, Jennifer ^{[1
]}

Fisher, Jennifer ^{[1
]}

Meredith, David ^{[7
]}

Murakami, Mark ^{[1
]}

Garcia, Yuri ^{[1
]}

Shipp, Margaret ^{[1
]}

Nayak, Lakshmi ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Massachusetts Gen Hosp, Boston, MA 02114 USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Ctr Neuro Oncol, Boston, MA USA

[5] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Dept Neurol,Div Neurooncol, Boston, MA USA

[6] Brigham & Womens Canc Ctr, Dana Farber, Boston, MA USA

[7] Brigham & Womens Hosp, Boston, MA USA

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CTIM-39

引用

页数：2

共 50 条

[1] Phase Ib Trial with Dose Expansion of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab and Lenalidomide in Patients with Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)
Grommes, Christian
Piotrowski, Anna
Pentsova, Elena
Nolan, Craig
Francis, Jasmine
DeAngelis, Lisa
Schaff, Lauren
Mellinghoff, Ingo K.
BLOOD, 2020, 136
[2] Phase Ib of Copanlisib in Combination with Ibrutinib in Recurrent/Refractory Primary CNS Lymphoma (PCNSL)
Grommes, Christian
Gavrilovic, Igor
Miller, Alexandra M.
Stone, Jacqueline B.
Kaley, Thomas
Madzsar, Juli T.
Schumpp, Alyssa
Butler, Brittany T.
Schaff, Lauren
Mellinghoff, Ingo K.
BLOOD, 2019, 134
[3] Phase Ib/II Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab and Lenalidomide in Refractory/Recurrent Primary (PCNSL) and Secondary Central Nervous System Lymphoma (SCNSL)
Grommes, Christian
Piotrowski, Anna
Pentsova, Elena
Gavrilovic, Igor
Stone, Jacqueline B.
Lin, Andrew
Wongchai, Venissala
Madzsar, Juli T.
Malani, Rachna
Nolan, Craig
Francis, Jasmine
DeAngelis, Lisa
Schaff, Lauren
Mellinghoff, Ingo K.
BLOOD, 2022, 140 : 3807 - 3808
[4] Recurrent primary central nervous system lymphoma (PCNSL) treated with pemetrexed
Altman, J. K.
Gallot, L.
Cohn, R.
Chandler, J.
Levy, R.
Getch, C.
Marymont, M.
Tellez, C.
Raizer, J. J.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[5] Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
Murakami, Mineko
Fujimaki, Takamitsu
Asano, Shuichiro
Nakaguchi, Hiroshi
Yamada, Shoko M.
Hoya, Katsumi
Yamazaki, Kazuto
Ishida, Yasuo
Matsuno, Akira
YONSEI MEDICAL JOURNAL, 2011, 52 (06) : 1031 - 1034
[6] Phase II trial of temsirolimus for relapsed/refractory primary central nervous system lymphoma (PCNSL)
Kiewe, P.
Martus, P.
Thiel, E.
Grobosch, T.
Schlegel, U.
Herlinger, U.
Dreyling, M.
Schmidt, C.
Korfel, A.
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 268 - 268
[7] Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma
Nayak, Lakshmi
Abrey, Lauren E.
Drappatz, Jan
Gilbert, Mark R.
Reardon, David A.
Wen, Patrick Y.
Prados, Michael
Deangelis, Lisa M.
Omuro, Antonio
LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 58 - 61
[8] Phase I study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Grommes, Christian
Kaley, Thomas Joseph
Nolan, Craig
Omuro, Antonio Marcilio Padula
Wolfe, Julia
Mellinghoff, Ingo K.
DeAngelis, Lisa Marie
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[9] Primary central nervous system lymphoma (PCNSL)
Korfel, A.
Schlegel, U.
ONKOLOGE, 2014, 20 (01): : 75 - 84
[10] Primary central nervous system lymphoma (PCNSL)
Pereira de Andrade Caires, Elizabete Maria
Freua, Fernando
Costa, Felipe D'Almeida
Moura, Fernanda Lemos
Peterlevitz, Marcos Aurelio
Zambon, Antonio Alberto
ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (05) : 428 - 429

← 1 2 3 4 5 →